Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14 may promote neurodegeneration.
LATEST NEWS
- Neuro-bio hosts the Tenants lunch for Culham Campus!
- Councillor Mark Lygo visits Neuro-Bio to meet with CEO & Founder Baroness Susan Greenfield
- Neuro-Bio attends the Global Mind Brain Health Summit at the University of Oxford
- Neuro-Bio visits Munich for the Brain-Nose Symposium, hosted by Noselab!
- Neuro-Bio’s CEO & Founder, Baroness Susan Greenfield attends DC Finance’s Global Family Office & High Net Worth Community 2025 London Conference